(Q87107296)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

Shilpi Chattopadhyay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sarah Siddiqui

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Md Salman Akhtar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Mohammad Zeeshan Najm

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

S V S Deo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

N K Shukla

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Syed Akhtar Husain

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

16 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

4517-4527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24430361%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13277-013-1594-1

5 March 2020

exact match

0 references

cites work

Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival

1 reference

12 December 2020

Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.

1 reference

12 December 2020

An efficient procedure for genotyping single nucleotide polymorphisms.

1 reference

12 December 2020

Presence of alternatively spliced transcripts of aromatase gene in human breast cancer.

1 reference

12 December 2020

Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women

1 reference

12 December 2020

Aromatase inhibitors in breast cancer

1 reference

12 December 2020

Trends in cancer incidence in female breast, cervix uteri, corpus uteri, and ovary in India

1 reference

12 December 2020

Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis

1 reference

12 December 2020

Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women

1 reference

12 December 2020

Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein

1 reference

12 December 2020

Is breast cancer the same disease in Asian and Western countries?

1 reference

12 December 2020

Cloning and characterization of human estrogen receptor beta promoter

1 reference

12 December 2020

Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study.

1 reference

12 December 2020

Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility

1 reference

12 December 2020

A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort

1 reference

12 December 2020

Association between CYP17 polymorphisms and the development of breast cancer

1 reference

12 December 2020

Epidemiology of breast cancer.

1 reference

12 December 2020

Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China

1 reference

12 December 2020

Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis

1 reference

12 December 2020

PvuII polymorphism of estrogen receptor-α gene in breast cancer.

1 reference

12 December 2020

Association of CYP17 genetic polymorphism with intra-tumoral estradiol concentrations but not with CYP17 messenger RNA levels in breast cancer tissue

1 reference

12 December 2020

Analysis of the ERalpha germline PvuII marker in breast cancer risk

1 reference

12 December 2020

Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility

1 reference

12 December 2020

Sources of estrogen and their importance

1 reference

12 December 2020

Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women

1 reference

12 December 2020

Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.

1 reference

12 December 2020

Estrogen receptor beta polymorphism is associated with prostate cancer risk

1 reference

12 December 2020

Tissue-specific, cyclic adenosine 3',5'-monophosphate-induced, and phorbol ester-repressed transcription from the human P450c17 promoter in mouse cells

1 reference

12 December 2020

No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer

1 reference

12 December 2020

Estrogen receptor alpha polymorphisms and postmenopausal breast cancer risk

1 reference

12 December 2020

The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer

1 reference

12 December 2020

Using genetic variation to study human disease

1 reference

12 December 2020

Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest

1 reference

12 December 2020

Estrogen carcinogenesis in breast cancer

1 reference

12 December 2020

Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer

1 reference

12 December 2020

A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitro.

1 reference

12 December 2020

Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones

1 reference

12 December 2020

Evaluation of functional genetic variants for breast cancer risk: results from the Shanghai breast cancer study

1 reference

12 December 2020

Time trend in breast and cervix cancer of women in India - (1990-2003).

1 reference

12 December 2020

A polymorphism in the CYP17 gene increases the risk of breast cancer

1 reference

12 December 2020

Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study

1 reference

12 December 2020

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).

1 reference

12 December 2020

Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood

1 reference

12 December 2020

Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project.

1 reference

12 December 2020

Genetic polymorphisms of the CYP19A1 gene and breast cancer survival

1 reference

12 December 2020

The magnitude of cancer breast in India: a summary

1 reference

12 December 2020

Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates.

1 reference

12 December 2020

CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1

1 reference

12 December 2020

Selected estrogen receptor 1 and androgen receptor gene polymorphisms in relation to risk of breast cancer and fibrocystic breast conditions among Chinese women

1 reference

12 December 2020

In situ aromatization enhances breast tumor estradiol levels and cellular proliferation.

1 reference

12 December 2020

Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients

1 reference

12 December 2020

Sex steroids and growth factors in the regulation of mammary gland proliferation, differentiation, and involution

1 reference

12 December 2020

Breast cancer risk associated with polymorphism in CYP19 in Japanese women

1 reference

12 December 2020

Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women

1 reference

12 December 2020

Molecular epidemiology of cancer

1 reference

12 December 2020

Global cancer statistics

1 reference

12 December 2020

Association between CYP17 gene polymorphism and risk of breast cancer in young women.

1 reference

12 December 2020

Breast cancer in developing countries

1 reference

12 December 2020

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

1 reference

12 December 2020

Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis.

1 reference

12 December 2020

CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.

1 reference

12 December 2020